|
December 21, 2000
PALADIN ACQUIRES CANADIAN RIGHTS TO TAPAZOLE® FROM LILLY
(Also in PDF
format)
December 19, 2000
PALADIN LABS INC. ANNOUCES TPP APPROVAL FOR APTHERA®
(Also in PDF
format)
December 11, 2000
NOW THERE IS A PLAN BT - THE MOST EFFECTIVE EMERGENCY CONTRACEPTIVE NOW AVAILABLE ACROSS CANADA
(Also in PDF
format)
December 1, 2000
PALADIN LABS INC. ANNOUCES TTP APPROVAL FOR ANTIZOL® - THE ONLY APPROVED PRODUCT FOR THE TREATMENT OF ETHYLENE GLYCOL POISONING
(Also in PDF
format)
November 19, 2000
PALADIN SIGNS CANADIAN MARKETING AND DISTRIBUTION AGREEMENT FOR MUSE
(Also in PDF
format)
October 30, 2000
PALADIN LABS INC. ANNOUNCES THIRD QUARTER FINANCIAL RESULTS
(Also in PDF
format)
October 10, 2000
PALADIN LABS INC. ANNOUNCES RESULTS OF CONNETICS CORPORATION'S RELAXIN PHASE
II/III STUDY
September 5, 2000
PALADIN LICENSES PORTFOLIO OF INNOVATIVE HORMONE REPLACEMENT THERAPIES FROM
BIOSANTE
August 9, 2000
PALADIN
LABS INC. ANNOUNCES SECOND QUARTER FINANCIAL RESULTS
July 25, 2000
CELL
PATHWAYS CONTRACTS WITH PALADIN LABS FOR MARKETING AND DISTRIBUTION OF
APTOSYNTM IN CANADA
July 17, 2000
PALADIN
LABS INC. RECEIVES APPROVAL FOR THE SALE OF VALTAXINTM
July 5, 2000
SKYEPHARMA
GRANTS EXCLUSIVE CANADIAN MARKETING AND DISTRIBUTION RIGHTS FOR
DEPOCYTTM TO PALADIN LABS
May 16, 2000
PALADIN LABS INC. GRANTED CANADIAN DISTRIBUTION RIGHTS FOR TESTOSTERONE
TRANSDERMAL SYSTEM FROM WATSON PHARMACEUTICALS, INC.
May 10, 2000
PALADIN LABS INC. REPORTS 14% INCREASE IN REVENUES FOR FIRST QUARTER, 2000
April 20, 2000
PALADIN LABS COMPLETES PUBLIC ISSUE OF 2,900,000 COMMON SHARES
April 12, 2000
PALADIN'S
PIPELINE MATURES
UNIPROST® POSTS POSITIVE RESULTS FROM PIVOTAL PHASE III
study; SYNSORB CD® COMMENCES PHASE III TRIAL
April 10, 2000
PALADIN LABS ISSUES 2,900,000 COMMON SHARES FROM TREASURY PURSUANT TO PUBLIC
OFFERING
March 22, 2000
PALADIN LABS ANNOUNCES EXPANDED CLINICAL DEVELOPMENT PROGRAM FOR CONXN®
March 16, 2000
PALADIN AND MDS ANNOUNCE AVAILABILITY OF NMP22® TEST FOR BLADDER CANCER IN MDS LABS
March 8, 2000
PALADIN
LABS ANNOUNCES RECORD REVENUES AND NET INCOME FOR FISCAL YEAR ENDING
DECEMBER 31, 1999 - For Immediate Release -
March 7, 2000
PALADIN
LABS ANNOUNCES PUBLIC OFFERING
February 22, 2000
UNITED
THERAPEUTICS SIGNS CANADIAN DISTRIBUTION AGREEMENT WITH PALADIN LABS
FOR UNIPROST
February 9, 2000
PALADIN LABS INC. ANNOUNCES APPROVAL FOR THE SALE OF PLAN BTM
- THE NEXT GENERATION MORNING AFTER PILL
February 3, 2000
PALADIN LABS INC. COMMENCED TRADING ON THE TORONTO STOCK EXCHANGE
Send comments,
corrections, and suggestions to info@paladin-labs.com
© 2006 Paladin Labs, Inc., All Rights Reserved. Legal
Terms and Notices (The Fine Print)
|
